Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 1:39 pm Sale | 2025-06-30 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 32,430,690 4.100% | -7,918,625 (-19.63%) | Filing History |
| 2025-08-14 11:15 am Sale | 2025-06-30 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 17,688,592 11.100% | -5,046,529 (-22.20%) | Filing History |
| 2025-06-11 7:51 pm Purchase | 2025-06-04 | 13G | Mereo BioPharma Group plc MREO | Northpond Ventures, LP | 54,521,000 6.900% | 54,521,000 (New Position) | Filing History |
| 2025-05-15 10:46 am Sale | 2025-03-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 33,421,235 4.200% | -14,249,615 (-29.89%) | Filing History |
| 2025-05-14 4:34 pm Purchase | 2025-03-31 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 22,735,121 14.300% | 6,817,862 (+42.83%) | Filing History |
| 2025-05-12 09:01 am Purchase | 2025-03-31 | 13G | Mereo BioPharma Group plc MREO | Adage Capital Management, L.P. | 8,503,780 1.070% | 8,503,780 (New Position) | Filing History |
| 2025-04-04 12:39 pm Purchase | 2025-04-01 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 40,349,315 5.100% | 40,349,315 (New Position) | Filing History |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | Mereo BioPharma Group plc MREO | ADAGE CAPITAL PARTNERS GP L.L.C. | 43,575,065 5.620% | -6,674,935 (-13.28%) | Filing History |
| 2024-12-06 11:37 am Purchase | 2024-11-29 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 15,917,259 10.300% | 3,571,393 (+28.93%) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | Suvretta Capital Management, LLC | 0 0.000% | -36,854,190 (Position Closed) | Filing History |
| 2024-11-14 3:30 pm Sale | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | Soleus Private Equity Fund III, L.P. | 4,234,765 0.500% | -44,652,330 (-91.34%) | Filing History |
| 2024-11-14 11:44 am Purchase | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 12,345,866 8.000% | 4,400,162 (+55.38%) | Filing History |
| 2024-11-12 4:49 pm Purchase | 2024-09-30 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 47,670,850 6.200% | 7,751,595 (+19.42%) | Filing History |
| 2024-07-11 11:46 am Purchase | 2024-07-01 | 13G | Mereo BioPharma Group plc MREO | JANUS HENDERSON GROUP PLC JHG | 7,945,704 5.200% | 7,945,704 (New Position) | Filing History |
| 2024-06-17 4:32 pm Purchase | 2024-06-17 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750 (+8.80%) | Filing History |
| 2024-04-16 2:58 pm Purchase | 2024-04-15 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 99,714,985 14.220% | 10,100 (+0.01%) | Filing History |
| 2024-02-14 6:51 pm Sale | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 0 0.000% | -10,378,591 (Position Closed) | Filing History |
| 2024-02-14 2:11 pm Unchanged | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 39,919,255 5.690% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:10 pm Purchase | 2023-07-03 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 39,919,255 6.380% | 8,694,770 (+27.85%) | Filing History |
| 2024-02-14 12:36 pm Purchase | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | MANGROVE PARTNERS IM LLC | 43,764,465 6.240% | 43,764,465 (New Position) | Filing History |